×
About 3,239 results

ALLMedicine™ Medullary Thyroid Carcinoma Center

Research & Reviews  1,609 results

miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targ...
https://doi.org/10.3892/mmr.2020.11392
Molecular Medicine Reports; Liu T, Meng J et. al.

Sep 18th, 2020 - Medullary thyroid carcinoma (MTC) is a relatively rare subtype of thyroid cancer, accounting for 5‑10% of all cases of thyroid cancer worldwide. Due to the current lack of knowledge regarding the tumorigenesis of MTC, the clinical treatment of MTC...

Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their pro...
https://doi.org/10.1136/jitc-2020-000638
Journal for Immunotherapy of Cancer; Rabold K, Aschenbrenner A et. al.

Sep 18th, 2020 - Tumor-associated macrophages (TAMs) are key components of the tumor microenvironment (TME) in non-medullary thyroid carcinoma (TC) and neuroblastoma (NB), being associated with a poor prognosis for patients. However, little is known about how tumo...

Molecular diagnosis and treatment of multiple endocrine neoplasia type 2B in Ethnic Han...
https://doi.org/10.2174/1871530320666200910112230
Endocrine, Metabolic & Immune Disorders Drug Targets; Zhang ZW, Guo X et. al.

Sep 11th, 2020 - Multiple endocrine neoplasia type 2B (MEN 2B) is mainly caused by M918T RET germline mutation, and characterized by medullary thyroid carcinoma (MTC), pheochromocytoma (PHEO) and non-endocrine features. However, the diagnosis and treatment are usu...

Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region.
https://doi.org/10.1002/dc.24586
Diagnostic Cytopathology REFERENCES; Liu CY, Bychkov A et. al.

Aug 21st, 2020 - The accurate preoperative identification of medullary thyroid carcinoma (MTC) is challenging due to the rarity of tumor and variable cytologic appearance. The Asian experience with diagnosing MTC by fine-needle aspiration (FNA) was scarcely report...

Comparison Between Familial and Sporadic Non-medullary Thyroid Carcinoma: A Retrospecti...
https://doi.org/10.1245/s10434-020-09025-0
Annals of Surgical Oncology; Lee YM, Jeon MJ et. al.

Aug 13th, 2020 - This study aimed to compare clinicopathologic features and outcomes between patients with familial non-medullary thyroid carcinoma (FNMTC) and patients with sporadic non-medullary thyroid carcinoma (SNMTC) after performing individual risk factor-m...

see more →

Guidelines  2 results

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Workin...
https://doi.org/10.1007/s12094-015-1465-x
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico; Grande E, Santamaría Sandi J et. al.

Dec 21st, 2015 - Of all thyroid cancers, <5 % are medullary (MTC). It is a well-characterized neuroendocrine tumor arising from calcitonin-secreting C cells, and RET gene plays a central role on its pathogeny. The electronic search was conducted using MEDLINE (Pub...

Revised American Thyroid Association guidelines for the management of medullary thyroid...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490627
Thyroid : Official Journal of the American Thyroid Association; Wells SA, Asa SL et. al.

Mar 26th, 2015 - The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. The Task Force identified relevant articles using a systematic PubMed...

see more →

Clinicaltrials.gov  1,621 results

miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targ...
https://doi.org/10.3892/mmr.2020.11392
Molecular Medicine Reports; Liu T, Meng J et. al.

Sep 18th, 2020 - Medullary thyroid carcinoma (MTC) is a relatively rare subtype of thyroid cancer, accounting for 5‑10% of all cases of thyroid cancer worldwide. Due to the current lack of knowledge regarding the tumorigenesis of MTC, the clinical treatment of MTC...

Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their pro...
https://doi.org/10.1136/jitc-2020-000638
Journal for Immunotherapy of Cancer; Rabold K, Aschenbrenner A et. al.

Sep 18th, 2020 - Tumor-associated macrophages (TAMs) are key components of the tumor microenvironment (TME) in non-medullary thyroid carcinoma (TC) and neuroblastoma (NB), being associated with a poor prognosis for patients. However, little is known about how tumo...

Molecular diagnosis and treatment of multiple endocrine neoplasia type 2B in Ethnic Han...
https://doi.org/10.2174/1871530320666200910112230
Endocrine, Metabolic & Immune Disorders Drug Targets; Zhang ZW, Guo X et. al.

Sep 11th, 2020 - Multiple endocrine neoplasia type 2B (MEN 2B) is mainly caused by M918T RET germline mutation, and characterized by medullary thyroid carcinoma (MTC), pheochromocytoma (PHEO) and non-endocrine features. However, the diagnosis and treatment are usu...

Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region.
https://doi.org/10.1002/dc.24586
Diagnostic Cytopathology REFERENCES; Liu CY, Bychkov A et. al.

Aug 21st, 2020 - The accurate preoperative identification of medullary thyroid carcinoma (MTC) is challenging due to the rarity of tumor and variable cytologic appearance. The Asian experience with diagnosing MTC by fine-needle aspiration (FNA) was scarcely report...

Comparison Between Familial and Sporadic Non-medullary Thyroid Carcinoma: A Retrospecti...
https://doi.org/10.1245/s10434-020-09025-0
Annals of Surgical Oncology; Lee YM, Jeon MJ et. al.

Aug 13th, 2020 - This study aimed to compare clinicopathologic features and outcomes between patients with familial non-medullary thyroid carcinoma (FNMTC) and patients with sporadic non-medullary thyroid carcinoma (SNMTC) after performing individual risk factor-m...

see more →

News  7 results

Scapular rash and endocrine neoplasia
https://www.mdedge.com/ccjm/article/150352/dermatology/scapular-rash-and-endocrine-neoplasia?channel=162
Muhammed Razmi T, MD, DNB, Debajyoti Chatterjee, MD et. al.

Nov 1st, 2017 - A woman in her 30s presented with an itchy skin-colored rash over her left scapular region that had first appeared 8 years earlier. It had started as itchy skin-colored papules that coalesced to a patch and later became hyperpigmented because of r.

Thyroid Ca: Initial Neck Dissection May Cut Recurrence Risk
https://www.medpagetoday.com/endocrinology/thyroid/68165

Sep 27th, 2017 - Action Points Among those with medullary thyroid carcinoma (MTC), lymph node dissection seemed to decrease local recurrences. Note that guidelines from the American Thyroid Association recommend all patients with known MTC undergo surgery to remov...

Renal cell carcinoma approval adds another notch to cabozantinib’s belt
https://www.mdedge.com/hematology-oncology/article/118588/genitourinary-cancer/renal-cell-carcinoma-approval-adds-another
Edited by Jame Abraham, MD et. al.

Nov 21st, 2016 - In April this year, the US Food and Drug Administration awarded regulatory approval to cabozantinib for the treatment of advanced renal cell carcinoma patients previously treated with anti-angiogenic therapy. 1 The small-molecule inhibitor, which.

ASCO 2010: Vandetanib Extends PFS in Medullary Thyroid Carcinoma
https://www.onclive.com/publications/obtn/2010/july-2010/asco-2010-vandetanib-extends-pfs-in-medullary-thyroid-carcinoma

Aug 13th, 2010 - Data from the phase III ZETA trial show that vandetanib (Zactima), a selective tyrosine kinase inhibitor, significantly slows the progression of advanced medullary thyroid carcinoma (MTC), a rare disease more diffi cult to treat than common thyroi...

Thyroid Removal Prevents Hereditary Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/1738

Sep 15th, 2005 - Action Points Advise patients that genetic testing can reliably spot children at risk for multiple endocrine neoplasia type 2A. Note that in this study, removal of the thyroid appeared to prevent the later occurrence of medullary thyroid carcinoma...

see more →